ZBH vs. HOLX

Last updated Jun 4, 2026

ZBH (Zimmer Biomet Holdings, Inc.) and HOLX (Hologic, Inc.) are both stocks. Both are in the Healthcare sector — ZBH in Medical Devices, HOLX in Medical Instruments & Supplies. At a 0.39 correlation, their price movements are largely independent.

Performance

ZBH vs. HOLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zimmer Biomet Holdings, Inc. (ZBH) and Hologic, Inc. (HOLX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ZBH

• 1D: 1.47%
• 1M: 2.79%
• YTD: -5.24%
• 6M: -8.23%
• 1Y: -6.51%
• 3Y*: -12.39%
• 5Y*: -10.52%
• 10Y*: -2.46%

HOLX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ZBH vs. HOLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ZBH Zimmer Biomet Holdings, Inc.	-5.24%	-14.03%	-12.46%	-3.81%	4.24%	-17.02%	3.77%	45.37%	-13.30%	17.86%
HOLX Hologic, Inc.	2.04%	3.33%	0.90%	-4.49%	-2.29%	5.12%	39.49%	27.03%	-3.86%	6.56%

Correlation

The correlation between ZBH and HOLX is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.33
Correlation (3Y) Calculated over the trailing 3-year period	0.43
Correlation (5Y) Calculated over the trailing 5-year period	0.42
Correlation (10Y) Calculated over the trailing 10-year period	0.45
Correlation (All Time) Calculated using the full available price history since Jul 26, 2001	0.39

The correlation between ZBH and HOLX shifts across timeframes, from 0.33 (1 year) to 0.45 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ZBH : $16.64B HOLX : $17.17B
EPS ZBH : $3.85 HOLX : $2.41
PE Ratio ZBH : 22.07 HOLX : 31.54
PS Ratio ZBH : 2.00 HOLX : 4.16
PB Ratio ZBH : 1.13 HOLX : 3.27
Total Revenue (TTM) ZBH : $8.41B HOLX : $4.13B
Gross Profit (TTM) ZBH : $5.89B HOLX : $2.18B
EBITDA (TTM) ZBH : $2.21B HOLX : $1.01B

Return for Risk

ZBH vs. HOLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZBH

ZBH Risk / Return Rank: 30
ZBH Sharpe Ratio Rank: 32
ZBH Sortino Ratio Rank: 28
ZBH Omega Ratio Rank: 28
ZBH Calmar Ratio Rank: 32
ZBH Martin Ratio Rank: 31

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZBH vs. HOLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and Hologic, Inc. (HOLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ZBH	HOLX	Difference
Sharpe ratio: Return per unit of total volatility	-0.22	—	—
Sortino ratio: Return per unit of downside risk	-0.08	—	—
Omega ratio: Gain probability vs. loss probability	0.99	—	—
Calmar ratio: Return relative to maximum drawdown	-0.26	—	—
Martin ratio: Return relative to average drawdown	-0.51	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	ZBH	HOLX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.22	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.40	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.09	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.18	—	—

Drawdowns

Drawdown Indicators

	ZBH	HOLX	Difference
Max Drawdown Largest peak-to-trough decline	-65.03%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-25.54%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-43.94%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-48.62%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-52.14%	—	—
Current Drawdown Current decline from peak	-48.89%	—	—
Average Drawdown Average peak-to-trough decline	-20.05%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	12.72%	—	—

Volatility

Volatility by Period

	ZBH	HOLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.44%	—	—
Volatility (6M) Calculated over the trailing 6-month period	20.09%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	30.38%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.60%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.43%	—	—

Dividends

ZBH vs. HOLX - Dividend Comparison

ZBH's dividend yield for the trailing twelve months is around 1.13%, while HOLX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HOLX Hologic, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ZBH Zimmer Biomet Holdings, Inc.	1.13%	1.07%	0.91%	0.79%	0.75%	0.76%	0.62%	0.64%	0.93%	0.80%	0.93%	0.86%

Financials

ZBH vs. HOLX - Profitability Comparison

The chart below illustrates the profitability comparison between Zimmer Biomet Holdings, Inc. and Hologic, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ZBH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.51B and revenue of 2.09B. Therefore, the gross margin over that period was 72.4%.

HOLX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hologic, Inc. reported a gross profit of 586.40M and revenue of 1.05B. Therefore, the gross margin over that period was 56.0%.

ZBH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported an operating income of 373.20M and revenue of 2.09B, resulting in an operating margin of 17.9%.

HOLX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hologic, Inc. reported an operating income of 237.00M and revenue of 1.05B, resulting in an operating margin of 22.6%.

ZBH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported a net income of 238.10M and revenue of 2.09B, resulting in a net margin of 11.4%.

HOLX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hologic, Inc. reported a net income of 179.10M and revenue of 1.05B, resulting in a net margin of 17.1%.

Frequently Asked Questions

Can I hold both ZBH and HOLX in my portfolio?

ZBH and HOLX have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.